Cognitive rehabilitation program to improve cognition of cancer patients treated with chemotherapy: A 3‐arm randomized trial. Issue 24 (30th September 2020)

• Record Type: Journal Article
• Authors: Dos Santos, Mélanie; Hardy‐Léger, Isabelle; Rigal, Olivier; Licaj, Idlir; Dauchy, Sarah; Levy, Christelle; Noal, Sabine; Segura, Carine; Delcambre, Corinne; Allouache, Djelila; Parzy, Aurélie; Barriere, Jérôme; Petit, Thierry; Lange, Marie; Capel, Aurélie; Clarisse, Bénédicte; Grellard, Jean Michel; Lefel, Johan; Joly, Florence
• Is Part Of: Cancer. Volume 126:Issue 24(2020)
• Page Start: 5328
• Page End: 5336
• Publication Date: 2020-09-30
• Subjects: cancer -- chemotherapy -- cognitive impairment -- cognitive rehabilitation -- supportive care; Cancer -- Periodicals; Cancer -- Cytopathology -- Periodicals; 616.99405
• DOI: 10.1002/cncr.33186
• Languages: English
• ISSNs: 0008-543X

Abstract

Abstract : Background: There is no treatment for cancer‐related cognitive impairment, an important adverse effect that negatively impacts quality of life (QOL). We conducted a 3‐arm randomized controlled trial to evaluate the impact of computer‐assisted cognitive rehabilitation (CR) on cognition, QOL, anxiety, and depression among cancer patients treated with chemotherapy. Methods: Patients who reported cognitive complaints during or after completing chemotherapy were randomly assigned to 1 of 3 12‐week CR programs: computer‐assisted CR with a neuropsychologist (experimental group A), home cognitive self‐exercises (active control group B), or phone follow‐up (active control group C). Subjective cognition was assessed by the Functional Assessment of Cancer Therapy–Cognitive Function (FACT‐Cog), objective cognition was assessed by neuropsychological tests, QOL was assessed by the FACT‐General, and depression and anxiety were assessed by psychological tests. The primary endpoint was the proportion of patients with a 7‐point improvement in the FACT‐Cog perceived cognitive impairment (PCI) score. Results: Among the 167 enrolled patients (median age, 51 years), group A had the highest proportion of patients with a 7‐point PCI improvement (75%), followed by groups B (59%) and C (57%), but the difference was not statistically significant ( P = .13). Compared with groups B and C, the mean difference in PCI score was significantly higher in group A ( P = .02), with better perceived cognitive abilities ( P < .01) and a significant improvement in working memory ( P = .03). Group A reported higher QOL related to cognition (FACT‐Cog QOL) ( P = .01) and improvement in depression symptoms ( P = .03). Conclusions: These results suggest a benefit of a computer‐based CR program in the management of cancer‐related cognitive impairment and complaints. Abstract : In this 3‐arm randomized clinical trial of 167 patients, computer‐assisted cognitive rehabilitation improved cognitive complaints, with significant improvement in working memory, quality of life related to cognition, and depression symptoms. Computer‐assisted cognitive rehabilitation is a compelling approach toward the management of cancer‐related cognitive impairment and complaints.